Table 2.
Patient Subgroup | Number of Patients | Total Number of Doses |
|
---|---|---|---|
Mean (SD) | Median (min, max) | ||
All patients | 140 | 3.3 (1.8) | 3.0 (1, 8) |
Hepatic function | |||
Normal | 103 | 3.3 (1.9) | 3.0 (1, 8) |
Impaired, by severity | |||
Mild | 34 | 3.6 (1.9) | 3.0 (1, 8) |
Moderate | 2 | 3.0 (0.0) | 3.0 (3, 3) |
Severe | 1 | 3.0 (NA) | 3.0 (3, 3) |
Renal function | |||
Normal | 130 | 3.3 (1.8) | 3.0 (1, 8) |
Impaired, by severity | |||
Mild | 5 | 4.2 (2.3) | 4.0 (2, 8) |
Moderate | 5 | 3.4 (1.1) | 3.0 (2, 5) |
max = maximum; min = minimum; NA = not applicable; SST 30 mcg = sufentanil sublingual tablet 30 mcg.